AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15729158 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonspecific prompting and reading back the list
Number of subjects: 123
Study 15729158 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementary techniques
Number of subjects: 123
Study 12815681 — intervention group
Group type: EXPERIMENTAL
Intervention: In vivo black blood MRI
Number of subjects: 37
Study 10555794 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyglactin 910-polydioxanon (PPP) used for reconstruction of the orbital roof
Number of subjects: 144
Study 10555794 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 144
Study 8646706 — intervention group
Group type: EXPERIMENTAL
Intervention: PAPNET
Number of subjects: 7
Study 8646706 — intervention group
Group type: COMPARATOR
Intervention: Conventional screening
Number of subjects: 7
Study 14766525 — intervention group
Group type: EXPERIMENTAL
Intervention: Intertask processing
Number of subjects: 48
Study 14766525 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratask processing
Number of subjects: 48
Study 14766525 — intervention group
Group type: COMPARATOR
Intervention: No additional processing
Number of subjects: 48
Study 6305244 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir, 5 mg/kg body weight at 8‐hour intervals for 5 days
Number of subjects: 31
Study 6305244 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 31
Study 30946349 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 cmH2O of PEEP
Number of subjects: 50
Study 30946349 — intervention group
Group type: COMPARATOR
Intervention: Zero‐PEEP (ZEEP)
Number of subjects: 50
Study 30223563 — intervention group
Group type: EXPERIMENTAL
Intervention: LFD and TP arm (80 g of TP/day) for seven days
Number of subjects: 19
Study 30223563 — intervention group
Group type: COMPARATOR
Intervention: LFD-only control arm
Number of subjects: 19
Study 26650831 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound (US)
Number of subjects: 182
Study 26650831 — intervention group
Group type: COMPARATOR
Intervention: Magnetic Resonance Imaging (MRI)
Number of subjects: 182
Study 24482313 — intervention group
Group type: EXPERIMENTAL
Intervention: OM-89
Number of subjects: 185
Study 24482313 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study 21947318 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (300 mg/day)
Number of subjects: 24
Study 21947318 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 21146672 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone at discharge
Number of subjects: 946
Study 21146672 — intervention group
Group type: COMPARATOR
Intervention: No spironolactone at discharge
Number of subjects: 946
Study 17931902 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation under anesthesia
Number of subjects: 125
Study 17931902 — intervention group
Group type: COMPARATOR
Intervention: Home exercises alone (control)
Number of subjects: 125
Study 17931902 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (manipulation and control)
Number of subjects: 125
Study 15981671 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc-DTPA aerosol scintigraphy
Number of subjects: 22
Study 15981671 — intervention group
Group type: COMPARATOR
Intervention: Control group (fifteen healthy voluntary controls)
Number of subjects: 22
Study 15981671 — intervention group
Group type: EXPERIMENTAL
Intervention: CO-diffusion parameters
Number of subjects: 22
Study 12873959 — intervention group
Group type: EXPERIMENTAL
Intervention: Isobaric bupivacaine (3.5 mL, 17.5 mg mixed with 1.5 mL normal saline)
Number of subjects: 40
Study 12873959 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypobaric bupivacaine (3.5 mL, 17.5 mg mixed with 1.5 mL distilled water)
Number of subjects: 40
Study 12873959 — intervention group
Group type: COMPARATOR
Intervention: Isobaric bupivacaine
Number of subjects: 40
Study 12873959 — intervention group
Group type: COMPARATOR
Intervention: Hypobaric bupivacaine
Number of subjects: 40
Study 10573245 — intervention group
Group type: EXPERIMENTAL
Intervention: Venturi masks (VMs)
Number of subjects: 18
Study 10573245 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal prongs (NPs)
Number of subjects: 18
Study 10573245 — intervention group
Group type: COMPARATOR
Intervention: Both VMs and NPs
Number of subjects: 18
Study 8671270 — intervention group
Group type: EXPERIMENTAL
Intervention: Interceed absorbable adhesion barrier
Number of subjects: 25
Study 8671270 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated ovaries)
Number of subjects: 25
Study 1882661 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-mg gemeprost (Cervagem) pessary
Number of subjects: 75
Study 1882661 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 6341159 — intervention group
Group type: EXPERIMENTAL
Intervention: Golytely (an electrolyte‐polyethylene glycol solution)
Number of subjects: 0
Study 6341159 — intervention group
Group type: COMPARATOR
Intervention: Standard 2- and 3-day bowel preparations
Number of subjects: 0
Study 29606196 — intervention group
Group type: EXPERIMENTAL
Intervention: Forest bathing group (forest)
Number of subjects: 0
Study 29606196 — intervention group
Group type: COMPARATOR
Intervention: Urban control group (city)
Number of subjects: 0
Study 27439012 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic Community Engagement (SCE) intervention
Number of subjects: 234
Study 27439012 — intervention group
Group type: COMPARATOR
Intervention: Financial incentives
Number of subjects: 234
Study 26083963 — intervention group
Group type: EXPERIMENTAL
Intervention: Stunted patients (height-for-age Z score < -2)
Number of subjects: 2542
Study 26083963 — intervention group
Group type: COMPARATOR
Intervention: Non-stunted patients (height-for-age Z score >= -2)
Number of subjects: 2542
Study 26083963 — intervention group
Group type: EXPERIMENTAL
Intervention: Stunted patients with hypoxaemic pneumonia
Number of subjects: 2542
Study 23403476 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 202
Study 23403476 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 20626604 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirodenafil 100 mg on demand for 12 weeks
Number of subjects: 112
Study 18852533 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (TU) 1000 mg every 6 to 9 weeks for 30 weeks, then 1000 mg every 12 weeks for 114 weeks
Number of subjects: 40
Study 18852533 — intervention group
Group type: COMPARATOR
Intervention: Testosterone enanthate (TE) 250 mg every 3 weeks for 30 weeks
Number of subjects: 40
Study 18852533 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (TU) 1000 mg every 12 weeks
Number of subjects: 40
Study 18852533 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (TU) and Testosterone enanthate (TE)
Number of subjects: 40
Study 17321921 — intervention group
Group type: EXPERIMENTAL
Intervention: Topographic method for ETT insertion depth
Number of subjects: 200
Study 17321921 — intervention group
Group type: COMPARATOR
Intervention: 21/23 cm insertion depth method (Control)
Number of subjects: 200
Study 12908943 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweat patch testing
Number of subjects: 9
Study 12908943 — intervention group
Group type: EXPERIMENTAL
Intervention: Drugwipe immunochemical strip test
Number of subjects: 9
Study 10899655 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel (T)
Number of subjects: 283
Study 10899655 — intervention group
Group type: COMPARATOR
Intervention: Sequential methotrexate and 5-fluorouracil (MF)
Number of subjects: 283
Study 8978519 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergonomic posture training
Number of subjects: 212
Study 8978519 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 212
Study 8978519 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration-dampening rivet guns
Number of subjects: 212
Study 8978519 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 212
Study 1378143 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous carvedilol (12.5 mg in 1 h)
Number of subjects: 6
Study 1378143 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral carvedilol (25 mg)
Number of subjects: 6
Study 1378143 — intervention group
Group type: EXPERIMENTAL
Intervention: R(+) enantiomer
Number of subjects: 6
Study 1378143 — intervention group
Group type: EXPERIMENTAL
Intervention: S(‐) enantiomer
Number of subjects: 6
Study 1378143 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol and carvedilol glucuronide
Number of subjects: 6
Study 1378143 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 6
Study 6689452 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear fluids initially, followed by increasing strengths of milk, in quarter strength steps
Number of subjects: 150
Study 6689452 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear fluids initially and then reintroducing full strength milk
Number of subjects: 150
Study 6689452 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing full strength milk
Number of subjects: 150
Study 6689452 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 150
Study 31092226 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined ACLR and LET
Number of subjects: 600
Study 31092226 — intervention group
Group type: COMPARATOR
Intervention: Standard single bundle hamstring ACLR
Number of subjects: 600
Study 29716903 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal integrative intervention (relaxation, guided imagery, moderate pressure massage, listening to music)
Number of subjects: 60
Study 29716903 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal integrative intervention
Number of subjects: 60
Study 27100788 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin (10 mg daily)
Number of subjects: 120
Study 27100788 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study 25543420 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (cutting method and western medication)
Number of subjects: 120
Study 25543420 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutting method
Number of subjects: 120
Study 25543420 — intervention group
Group type: COMPARATOR
Intervention: Western medication
Number of subjects: 120
Study 22632584 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar extension traction with stretching exercises and infrared radiation
Number of subjects: 80
Study 22632584 — intervention group
Group type: COMPARATOR
Intervention: Stretching exercises and infrared radiation alone
Number of subjects: 80
Study 19448389 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive home‐visit intervention (n=122)
Number of subjects: 243
Study 19448389 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=121)
Number of subjects: 243
Study 17560882 — intervention group
Group type: EXPERIMENTAL
Intervention: Procainamide
Number of subjects: 362
Study 17560882 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 362
Study 17560882 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 362
Study 17560882 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 362
Study 15076794 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial herbal-based formula (4 d x 6 caps.d(‐1) loading phase, 11 d x 3 caps.d(‐1) maintenance phase)
Number of subjects: 17
Study 15076794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 12364430 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide (40 micro g)
Number of subjects: 146
Study 12364430 — intervention group
Group type: COMPARATOR
Intervention: Alendronate (10 mg)
Number of subjects: 146
Study 9846026 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DM) 30 mg three times a day
Number of subjects: 60
Study 9846026 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 60
Study 8077527 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase or streptokinase therapy (group A)
Number of subjects: 7426
Study 8077527 — intervention group
Group type: COMPARATOR
Intervention: No reperfusion therapy (group B)
Number of subjects: 7426
Study 2534679 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrabenazine (TBZ)
Number of subjects: 11
Study 2534679 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 11
Study 1126582 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosol-spray M protein vaccine
Number of subjects: 43
Study 1126582 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 43
Study 30578152 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin
Number of subjects: 590
Study 30578152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 590
Study 27595389 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture-like TENS (2Hz, 200ms)
Number of subjects: 5
Study 27595389 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional TENS (80Hz, 200ms)
Number of subjects: 5
Study 27137146 — intervention group
Group type: EXPERIMENTAL
Intervention: ALO-02 capsule administered whole under fed conditions (high-fat breakfast ∼ 950 calories)
Number of subjects: 24
Study 27137146 — intervention group
Group type: COMPARATOR
Intervention: ALO-02 capsule administered whole under fasting conditions
Number of subjects: 24
Study 27137146 — intervention group
Group type: EXPERIMENTAL
Intervention: ALO-02 pellets sprinkled on applesauce under fasting conditions
Number of subjects: 24
Study 27137146 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 40 mg doses of ALO-02
Number of subjects: 24
Study 24004645 — intervention group
Group type: EXPERIMENTAL
Intervention: B-vitamins (folic acid 2 mg, vitamin B6 25 mg, vitamin B12 500 μg)
Number of subjects: 8164
Study 24004645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8164
Study 21406699 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% urea in a water-lipid-based foam containing lactic acid
Number of subjects: 12
Study 19441985 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel median-approach microendoscopic laminectomy
Number of subjects: 41
Study 19441985 — intervention group
Group type: COMPARATOR
Intervention: Conventional laminectomy
Number of subjects: 41
Study 17197015 — intervention group
Group type: EXPERIMENTAL
Intervention: Website-delivered physical activity intervention with repeated feedback
Number of subjects: 434
Study 17197015 — intervention group
Group type: EXPERIMENTAL
Intervention: Website-delivered physical activity intervention without repeated feedback
Number of subjects: 434
Study 17197015 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control group
Number of subjects: 434
Study 15527610 — intervention group
Group type: EXPERIMENTAL
Intervention: General practitioners' knowledge of PTSD management
Number of subjects: 0
Study 15527610 — intervention group
Group type: EXPERIMENTAL
Intervention: General practitioners' referral practices for PTSD
Number of subjects: 0
Study 15527610 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug treatment knowledge for PTSD
Number of subjects: 0
Study 15527610 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition and prescription knowledge for PTSD
Number of subjects: 0
Study 15527610 — intervention group
Group type: EXPERIMENTAL
Intervention: Best practice management for PTSD
Number of subjects: 0
Study 15527610 — intervention group
Group type: COMPARATOR
Intervention: Best practice management for depression
Number of subjects: 0
Study 15527610 — intervention group
Group type: COMPARATOR
Intervention: Recognition knowledge for depression
Number of subjects: 0
Study 11207629 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl oestradiol (30 microg, EE2)
Number of subjects: 17
Study 11207629 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose oral conjugated oestrogen (0.625 mg, CE)
Number of subjects: 17
Study 11207629 — intervention group
Group type: EXPERIMENTAL
Intervention: Both EE2 and CE
Number of subjects: 17
Study 9870553 — intervention group
Group type: EXPERIMENTAL
Intervention: D-alpha-tocopherol 2 g/day
Number of subjects: 50
Study 9870553 — intervention group
Group type: EXPERIMENTAL
Intervention: L-ascorbic acid 3 g/day
Number of subjects: 50
Study 9870553 — intervention group
Group type: EXPERIMENTAL
Intervention: D-alpha-tocopherol 2 g/day combined with L-ascorbic acid 3 g/day
Number of subjects: 50
Study 9870553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 8304606 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 100-mg rectal suppository
Number of subjects: 51
Study 8304606 — intervention group
Group type: COMPARATOR
Intervention: Morphine by IV titration (5-mg loading dose and up to two additional 2.5-mg doses if needed)
Number of subjects: 51
Study 2471005 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 17
Study 2471005 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 17
Study 31326995 — intervention group
Group type: EXPERIMENTAL
Intervention: EEL-enhanced IVOCT
Number of subjects: 200
Study 31326995 — intervention group
Group type: COMPARATOR
Intervention: Standard IVOCT
Number of subjects: 200
Study 30794165 — intervention group
Group type: EXPERIMENTAL
Intervention: Attended condition (self-paced dorsiflexion)
Number of subjects: 27
Study 30794165 — intervention group
Group type: EXPERIMENTAL
Intervention: Distracted condition (dual-task with oddball task)
Number of subjects: 27
Study 30794165 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of parietal channels
Number of subjects: 27
Study 30794165 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of central and parietal channels
Number of subjects: 27
Study 29197830 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 1590
Study 25899652 — intervention group
Group type: COMPARATOR
Intervention: IV phenytoin (PHT) 20mg/kg
Number of subjects: 44
Study 25899652 — intervention group
Group type: EXPERIMENTAL
Intervention: IV levetiracetam (LEV) 20mg/kg
Number of subjects: 44
Study 25899652 — intervention group
Group type: COMPARATOR
Intervention: IV phenytoin (PHT)
Number of subjects: 44
Study 25899652 — intervention group
Group type: EXPERIMENTAL
Intervention: IV levetiracetam (LEV)
Number of subjects: 44
Study 22777834 — intervention group
Group type: EXPERIMENTAL
Intervention: Cediranib (3 mg/kg per dose daily)
Number of subjects: 0
Study 22777834 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study 21482957 — intervention group
Group type: EXPERIMENTAL
Intervention: Vandetanib treatment for 6 weeks
Number of subjects: 17
Study 21482957 — intervention group
Group type: EXPERIMENTAL
Intervention: Vandetanib treatment
Number of subjects: 17
Study 21482957 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro analyses of cultured endothelial cells with vandetanib
Number of subjects: 17
Study 18608400 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly water exercise
Number of subjects: 22
Study 18608400 — intervention group
Group type: COMPARATOR
Intervention: Once-weekly water exercise
Number of subjects: 22
Study 18608400 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (once and twice weekly)
Number of subjects: 22
Study 16676338 — intervention group
Group type: EXPERIMENTAL
Intervention: Three dietary fibers with different levels of fermentability
Number of subjects: 0
Study 16676338 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 14581144 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin Lispro plus lunch and bedtime NPH insulin
Number of subjects: 60
Study 14581144 — intervention group
Group type: COMPARATOR
Intervention: Premeal regular insulin plus bedtime NPH insulin
Number of subjects: 60
Study 11872050 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening with a single ultrasonographic scan
Number of subjects: 9342
Study 11872050 — intervention group
Group type: COMPARATOR
Intervention: Control group (no screening)
Number of subjects: 9342
Study 9666870 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose carbimazole (100 mg per day plus thyroxine)
Number of subjects: 37
Study 9666870 — intervention group
Group type: COMPARATOR
Intervention: Low-dose carbimazole (starting at 25 mg, titrated)
Number of subjects: 37
Study 9666870 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose carbimazole
Number of subjects: 37
Study 9666870 — intervention group
Group type: COMPARATOR
Intervention: Low-dose carbimazole
Number of subjects: 37
Study 7664011 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 0
Study 7664011 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound surveillance
Number of subjects: 0
Study 2485286 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary incentive
Number of subjects: 70
Study 2485286 — intervention group
Group type: COMPARATOR
Intervention: No incentive
Number of subjects: 70
Study 2485286 — intervention group
Group type: EXPERIMENTAL
Intervention: Levine Hypothesis Test
Number of subjects: 70
Study 2485286 — intervention group
Group type: EXPERIMENTAL
Intervention: Conceptual Level Analogy Test
Number of subjects: 70
Study 13969 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromazepam (mean daily dose: 23.8 mg)
Number of subjects: 72
Study 13969 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (mean daily dose: 94 mg)
Number of subjects: 72
Study 13969 — intervention group
Group type: COMPARATOR
Intervention: Placebo (4.6 capsules)
Number of subjects: 72
Study 31288004 — intervention group
Group type: EXPERIMENTAL
Intervention: Î²-Cryptoxanthin (0-40 μM)
Number of subjects: 0
Study 28333252 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-layer plication with continuous 2-0 monofilament nylon suture (group I)
Number of subjects: 30
Study 28333252 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-layer plication with continuous barbed suture (group II)
Number of subjects: 30
Study 28333252 — intervention group
Group type: COMPARATOR
Intervention: Control group (two-layer plication with 2-0 monofilament nylon suture)
Number of subjects: 30
Study 25782367 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reports of medication side effects
Number of subjects: 111
Study 25782367 — intervention group
Group type: COMPARATOR
Intervention: Controlling for patient demographics, pain intensity, and negative affect
Number of subjects: 111